Compile Data Set for Download or QSAR
maximum 50k data
Found 11 of ic50 data for polymerid = 1749,1750
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185589(US9156852, 83 | USRE47451, Example 83)
Affinity DataIC50:  12nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185585(US9156852, 16 | USRE47451, Example 16)
Affinity DataIC50:  15nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  22nMpH: 8.2 T: 2°CAssay Description:The biochemical activity of compound was determined by incubation with Raf kinases and substrate MEK-1 in the presence of 1-10 uM ATP/ [gamma-32P] AT...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf [410-766,V600E](Homo sapiens (Human))
Bayer Pharmaceuticals

LigandPNGBDBM16673(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)
Affinity DataIC50:  38nMpH: 8.2 T: 2°CAssay Description:The biochemical activity of compound was determined by incubation with Raf kinases and substrate MEK-1 in the presence of 1-10 uM ATP/ [gamma-32P] AT...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185588(US9156852, 59 | USRE47451, Example 59)
Affinity DataIC50:  42nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185591(US9156852, 116 | USRE47451, Example 116)
Affinity DataIC50:  56nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185586(US9156852, 38 | USRE47451, Example 38)
Affinity DataIC50:  66nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185584(US9156852, 1 | USRE47451, Example 1)
Affinity DataIC50:  121nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185587(US9156852, 50 | USRE47451, Example 50)
Affinity DataIC50:  128nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM185590(US9156852, 105 | USRE47451, Example 105)
Affinity DataIC50:  179nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSerine/threonine-protein kinase B-raf [409-765](Homo sapiens (Human))
Hanmi Pharm.

US Patent
LigandPNGBDBM50396483(PLX-4032 | RG 7204 | Ro 5185426 | US10570155, Vemu...)
Affinity DataIC50:  344nMAssay Description:The compounds prepared in Examples were tested for inhibitory activity against three subtypes of RAF, i.e., RAF1 Y340D Y341D (C-RAF), B-RAF normal ty...More data for this Ligand-Target Pair